29.03.2012 • News

BioAmber Produces Bio-based 1,4-Butanediol

BioAmber has scaled up its hydrogenation catalyst technology under license from DuPont and converted multi-ton quantities of bio-succinic acid into 100% bio-based 1,4-butanediol (1,4-BDO), tetrahydrofuran (THF) and gamma-butyrolactone (GBL).

BioAmber believes the global addressable market for these products exceeds $4 billion, and that they are principally used to make polyesters, polyurethanes, spandex and biodegradable plastics.

Using bio-succinic acid made at its French facility as a starting material, BioAmber successfully completed a 1,4-BDO production campaign in collaboration with one of the world's leading commercial catalyst suppliers and a toll manufacturer possessing large-scale hydrogenation reactors and distillation columns.

"This is the culmination of two years of work and an important milestone in the development of our bio-based 1,4-BDO platform. We have been able to couple the DuPont catalyst technology with our bio-succinic acid production to manufacture high purity bio-based 1,4-BDO at demonstration scale," Jim Millis, BioAmber's Chief Technology Officer said. "We are developing an integrated plant engineering design that combines the production of bio-succinic acid and bio-based 1,4-BDO on a single site," he added.

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.